title: Acute effects of hydrocortisone on the metabolic response to a glucose load: increase in the first-phase insulin secretion.
abstract: OBJECTIVE
  Several basic science studies support the existence of non-genomic glucocorticoid signaling in pancreas, liver, and adipocytes, but its clinical relevance has not yet been elucidated. This study aimed at investigating the rapid effects of hydrocortisone on the human metabolic response to glucose.
  
  
  METHODS
  In a randomized placebo-controlled crossover study, ten healthy men received an i.v. bolus of 0.6 mg/kg hydrocortisone once and placebo once 4 min before the administration of 330 mg/kg glucose. Cortisol, glucose, insulin, C-peptide, ghrelin, and peptide YY (PYY) levels were measured during the following 3 h. Minimal model analysis was performed for evaluating the metabolic response.
  
  
  RESULTS
  Hydrocortisone attenuated the rise in plasma glucose during the initial 15 min following glucose administration (P=0.039), and it led to lower glucose levels during the first 2 h (P=0.017). This was accompanied by enhanced circulating insulin (P=0.02) and C-peptide (P=0.03) levels during the initial 15 min, and a 35% increase in the first-phase beta-cell function (P=0.003). Hydrocortisone decreased PYY concentrations during the initial 30 min (P=0.014), but it did not affect the ghrelin response to glucose.
  
  
  CONCLUSIONS
  One i.v. bolus of hydrocortisone induces rapid effects on carbohydrate metabolism increasing the first-phase beta-cell function. The modulation of PYY plasma levels suggests the possible non-genomic effects of glucocorticoids on appetite-regulatory hormones.
authors.affiliation: Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria. greisa.vila@meduniwien.ac.at
authors.forename: Greisa
authors.initials: G
authors.lastname: Vila
authors.forename: Michael
authors.initials: M
authors.lastname: Krebs
authors.forename: Michaela
authors.initials: M
authors.lastname: Riedl
authors.forename: Sabina M
authors.initials: SM
authors.lastname: Baumgartner-Parzer
authors.forename: Martin
authors.initials: M
authors.lastname: Clodi
authors.forename: Christina
authors.initials: C
authors.lastname: Maier
authors.forename: Giovanni
authors.initials: G
authors.lastname: Pacini
authors.forename: Anton
authors.initials: A
authors.lastname: Luger
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D019540:Area Under Curve; D001786:Blood Glucose / Q000187:drug effects*; D002096:C-Peptide / Q000097:blood; D018592:Cross-Over Studies; D054439:Ghrelin / Q000097:blood; D005947:Glucose / Q000494:pharmacology*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000494:pharmacology*; D007328:Insulin / Q000097:blood*; D008297:Male; D019894:Peptide YY / Q000097:blood; D011446:Prospective Studies; D016037:Single-Blind Method
chemical_list: D001786:Blood Glucose; D002096:C-Peptide; D054439:Ghrelin; D007328:Insulin; D019894:Peptide YY; D005947:Glucose; D006854:Hydrocortisone